Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3381eaaea8bc967177088b4f2d800cf2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D411-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate |
1992-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a46041992dd0ea27527aa290922607b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ee020e91b33c858bdbbef7464a3b4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_011403516bb746950983934d4ee49213 |
publicationDate |
1998-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2102393-C1 |
titleOfInvention |
(-)-cis-4-amino-1-(2-oxymethyl-1,3-oxathiolan-5-yl-(1h)-pyrimidine-2-on in crystalline forms, method for their production and pharmaceutical composition |
abstract |
FIELD: medicine. SUBSTANCE: (-)-cis-4-amino-1-(oxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidine-2-on in crystalline form, particularly, as needle or bipyramidal crystals and pharmaceutical compositions on their base and their production are disclosed here. Compounds and compositions may be used in medicine. EFFECT: improved quality. 21 cl |
priorityDate |
1991-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |